IGC IGC Pharma, Inc.

-

IGC Pharma Missed Consensus Estimates

Friday, August 14, 2026 · 12:00 AM ET

IGC Pharma (IGC) reported a loss of $0.03 per share on revenue of $0.27 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.02 per share on revenue of $0.16 million. The company missed consensus estimates by 50.00% while revenue fell 19.21% compared to the same quarter a year ago.

India Globalization Capital Inc is engaged in acquiring, incubating, financing and growing companies in multiple industries & locations. The Company trades iron ore & lease construction equipment in India; and operates iron ore plants in China.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.03)
Earnings Whisper®
Consensus Estimate
($0.02)
Earnings Surprise
Earnings Growth-50.0 %
Reported Revenue
$0.27M
Revenue Estimate
$0.16M
Revenue Surprise
Revenue Growth-19.2 %